Clinical Trial in Ayurveda for Rheumatoid Arthritis

March 24, 2022

The Ministry of Ayush has launched the world’s first multicenter phase III clinical trial that will be assessing Ayurveda’s efficacy in Rheumatoid Arthritis treatment.

Overview:

In accordance with the stringent guidelines of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use – Good Clinical Practice, this trial will be conducted.
This trial will be monitored by Dr Daniel Erick Furst who is a world-renowned rheumatologist from the University of California.
The AVP Research Foundation, affiliated to the Arya Vaidya Pharmacy (Coimbatore) Ltd and the Central Council for Research in Ayurveda (CCRAS), Ministry of Ayush will be conducting these trials.

When will this study begin?

In May 2022 the study is expected to begin and will be completed in the next two years. The sample size for this study has been increased by almost 5 times, to 240 patients from 48.

Where will the clinical trials be conducted?

At three locations the clinical trials will be conducted. They are Central Ayurveda Research Institute for Metabolic Disorders, Bengaluru, AVP Research Foundation, Coimbatore, and the Raja Ramdeo Anandilala Central Ayurveda Research Institute for Cancer, Mumbai.

About Rheumatoid Arthritis

Rheumatoid arthritis is an inflammatory autoimmune disease in which the body’s immune system attacks the healthy cells by mistake. This causes inflammation in the body parts that are affected. This disease mainly occurs in the joints like the joints in the wrists, hands, and knees.

« Previous Post Next Post »